Covid 19 Timeline of Events in Andover: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
''' | |||
JULY 2020''' | |||
'''Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.'''<br> | '''Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.'''<br> In July 2020, Pfizer's Andover facility began mass manufacturing the RNA required for the mRNA vaccine it co-developed with the German pharmaceutical firm, BioNTech. Sold under the brand name Comirnity, [https://en.wikipedia.org/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine the Pfizer BioNTech Covid-19 vaccine] production and trials were sped up and scaled up to meet the need for 50 million doses by the end of 2021. <ref> Andover's Piece of the Vaccine, ''The Eagle Tribune'', December 20, 2020. </ref> | ||
Revision as of 17:32, 24 January 2024
JULY 2020
Pfizer Inc.'s Andover facility played a critical role in the development of the first mRNA vaccines in 2020.
In July 2020, Pfizer's Andover facility began mass manufacturing the RNA required for the mRNA vaccine it co-developed with the German pharmaceutical firm, BioNTech. Sold under the brand name Comirnity, the Pfizer BioNTech Covid-19 vaccine production and trials were sped up and scaled up to meet the need for 50 million doses by the end of 2021. [1]
- ↑ Andover's Piece of the Vaccine, The Eagle Tribune, December 20, 2020.